SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19

Alexi Vasbinder(University of Washington), Tariq U. Azam(University of Michigan), Rodica Pop‐Busui(University of Michigan), D. A. Roberts(University of Michigan), Erinleigh Michaud(University of Michigan), Feriel Presswalla(University of Michigan), Chelsea Meloche(University of Michigan), Kristen Machado(University of Michigan), Patrick O’Hayer(University of Michigan), Élizabeth Anderson(Wellcome Sanger Institute), Hanna Berlin(University of Michigan), Pennelope Blakely(University of Michigan), Sven H. Loosen(Düsseldorf University Hospital), Husam Shadid(University of Michigan), Rafey Feroze(University Hospitals of Cleveland), Line Jee Hartmann Rasmussen(Hvidovre Hospital), Tonimarie Catalan(University of Michigan), Michael Pan(The University of Melbourne), Jesper Eugen‐Olsen(Amager Hospital), Jochen Reiser(The University of Texas Medical Branch at Galveston), Athanasios Chalkias(University of Thessaly), Christina Hutten(University of Michigan), Frank Tacke(Charité - Universitätsmedizin Berlin), Salim S. Hayek(Rush University Medical Center), Lili Zhao(University of Michigan), Ian Pizzo(Michigan Medicine), Venkatesh L. Murthy(Rush University Medical Center), Anis Ismail(University of Michigan), Mousumi Banerjee(University of Michigan), Yiyuan Huang(Affiliated Hospital of Youjiang Medical University for Nationalities), Christopher Launius(University of Michigan), Evangelos J. Giamarellos‐Bourboulis(National and Kapodistrian University of Athens), Kishan Padalia(University of Michigan)
Journal of Medical Virology
January 1, 2024
Cited by 14


Related Papers